Indian wastewater rife with drug resistance genes
Urban wastewater in India is emerging as a critical reservoir of antimicrobial resistance – with researchers urging expanded surveillance to detect outbreaks early and address gaps in policy implementation.
Abatify Summary
**The proliferation of antimicrobial resistance (AMR) in wastewater systems poses a severe threat to aquatic biodiversity and the integrity of Nature-Based Solutions (NbS) by disrupting essential microbial functions.**
- AMR genes in urban runoff alter the microbial composition of surrounding wetlands and riparian zones, potentially degrading their natural carbon sequestration capacity.
- Contaminated water discharge compromises the 'Do No Significant Harm' (DNSH) criteria for Blue Carbon and LULUCF projects, introducing biological risks to indigenous flora and fauna.
- The long-term stability of aquatic ecosystems is undermined as drug-resistant pathogens disrupt nutrient cycling and the primary productivity required for ecological resilience.
**Systemic failures in wastewater policy and surveillance create significant liability risks for infrastructure projects and may lead to 'integrity discounts' for carbon credits under ICVCM Core Carbon Principles (CCPs).**
- A lack of stringent AMR regulation reflects a policy gap that could impact the valuation of Article 6.4 emission reductions derived from urban water management and methane capture.
- Market pricing for technical removals and wastewater-to-energy credits may face downward pressure if projects cannot demonstrate robust environmental safeguards against genetic pollution.
- Corporate compliance with SBTi Nature targets and B Corp status will increasingly necessitate end-to-end water stewardship that accounts for Scope 3 pathogen risks in global supply chains.
